Share Twitter LinkedIn Facebook Email Thanos Zomas, MD of @TakedaOncology on brentuximab vedotin with chemotherapy for stage 3/4 classical hodgkin lymphoma (cHL): what’s next in research and exciting news at ASH 2019
Asciminib: ASH 2022 Prof. Tim Hughes Studies For patients With CML Chronic Myelogenous Leukemia 7 Mins Read